Wealthspire Advisors (New York)’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,551
Closed -$724K 1003
2025
Q4
$724K Buy
1,551
+1,414
+1,032% +$656K 0.01% 508
2025
Q3
$58.3K Buy
+137
New +$53.1K ﹤0.01% 1188
2021
Q2
Sell
-2,808
Closed -$529K 498
2021
Q1
$529K Buy
2,808
+356
+15% +$62.8K 0.01% 382
2020
Q4
$403K Buy
2,452
+788
+47% +$115K 0.01% 347
2020
Q3
$207K Buy
+1,664
New +$206K 0.01% 299
2020
Q2
Sell
-3,042
Closed -$273K 378
2020
Q1
$273K Buy
+3,042
New +$394K 0.01% 407
2019
Q1
Sell
-211
Closed -$26K 361
2018
Q4
$26K Buy
+211
New +$28.3K ﹤0.01% 285

Other funds holding HCA

Wealthspire Advisors (New York)'s HCA Position: Q1 2026 in Review

Wealthspire Advisors (New York) sold out of HCA Healthcare (HCA) in Q1 2026, closing a stake of 1,551 shares — an estimated $724K sold.

Wealthspire Advisors (New York) first reported a position in HCA in Q4 2018 and held it in 7 quarters. The position peaked at $724K in Q4 2025. 1,418 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Wealthspire Advisors (New York) reported no remaining HCA Healthcare position as of Q1 2026 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 1,551 HCA Healthcare shares in Q1 2026, an estimated $724K.
  • Wealthspire Advisors (New York) first reported a position in HCA Healthcare in Q4 2018 and held it in 7 quarters.
  • Wealthspire Advisors (New York)'s HCA Healthcare position peaked at $724K in Q4 2025.
  • 1,418 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.